+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cell-free Tumor DNA Detection Market - Global Forecast 2026-2032- Product Image
Cell-free Tumor DNA Detection Market - Global Forecast 2026-2032- Product Image
New

Cell-free Tumor DNA Detection Market - Global Forecast 2026-2032

  • Report

  • 194 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6280869
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Cell-Free Tumor DNA Detection: Executive Overview

Cell-free tumor DNA (ctDNA) detection analyzes tumor-derived DNA fragments circulating in blood and other body fluids. Its clinical relevance comes from the possibility of obtaining molecular information through minimally invasive sampling, supporting applications such as treatment selection, response assessment, molecular residual disease evaluation, and recurrence surveillance. Assay performance depends on tumor shedding, disease burden, specimen quality, sequencing or amplification strategy, and the clinical context in which testing is used.

Clinical Workflows Are Shifting Toward Serial Molecular Monitoring

The field is moving from isolated diagnostic testing toward longitudinal monitoring integrated with imaging, pathology, and routine clinical assessment. Improvements in molecular barcoding, error suppression, fragment analysis, methylation profiling, and multimodal interpretation are addressing the challenge of detecting very low concentrations of ctDNA. Adoption is also shaped by laboratory accreditation, validation requirements, reimbursement pathways, turnaround-time expectations, and the need for prospective evidence demonstrating clinical utility.

Artificial Intelligence Is Strengthening Signal Interpretation and Workflow Design

Artificial intelligence can support ctDNA workflows by distinguishing true tumor-derived variants from sequencing artifacts, prioritizing clinically relevant alterations, integrating fragmentomic and methylation features, and combining liquid-biopsy findings with pathology and imaging. Its practical value depends on representative training data, transparent validation, calibrated confidence estimates, and safeguards against population or specimen bias. Human review remains important for quality control, molecular tumor-board interpretation, and decisions with material clinical consequences.

Regional Insights: Regulation, Infrastructure, and Access Shape Adoption

North America combines advanced molecular diagnostics infrastructure with active clinical-trial networks and established regulatory pathways, while access and reimbursement remain important implementation constraints. Europe benefits from strong academic and hospital laboratory capabilities, but adoption can vary across national health systems and regulatory environments. Asia-Pacific includes highly capable research and diagnostic centers alongside substantial differences in laboratory capacity, reimbursement, and rural access. Latin America is developing expertise through reference laboratories and oncology networks, with affordability and logistics influencing availability. The Middle East is investing in precision-medicine infrastructure, although adoption differs by country and health-system maturity. Africa has important opportunities for noninvasive testing, but faces constraints related to laboratory capacity, sample transport, specialist availability, and sustainable financing.

Group Insights: Economic and Security Alliances Create Uneven Readiness

ASEAN countries show varied readiness, with metropolitan oncology centers and regional laboratory networks advancing faster than less-resourced settings. BRICS members have substantial scientific and clinical capabilities but differ widely in regulatory coordination, reimbursement, and access beyond major cities. The European Union benefits from cross-border research collaboration and shared regulatory principles, while national implementation and health-technology assessment remain decisive. G7 members generally possess strong translational infrastructure, though evidence standards and coverage decisions still differ. GCC countries are expanding precision-oncology capacity through centralized services and international collaboration. NATO members span mature and emerging diagnostic systems, making interoperability, procurement resilience, and equitable access relevant considerations.

Country Insights: National Systems Determine Clinical Integration

Australia has strong genomics research and specialist laboratory capacity, while geographic dispersion makes logistics important. Brazil and Mexico are expanding precision-oncology services, with regional inequality and public-system affordability shaping access. Canada and the United States have extensive clinical research and laboratory networks, but coverage, validation, and implementation differ across jurisdictions and payers. China, India, Japan, and South Korea combine advanced centers with varying regional access and regulatory pathways. France, Germany, Italy, Spain, and the United Kingdom have substantial hospital and academic expertise, with adoption influenced by national evidence, procurement, and reimbursement processes. Russia has relevant scientific capabilities, while infrastructure continuity, access to specialized reagents, and international collaboration affect implementation.

Industry Priorities: Prove Utility, Standardize Testing, and Build Trust

Leaders should prioritize clinically meaningful validation in clearly defined use cases rather than relying solely on analytical performance. Harmonized preanalytical procedures, reference materials, quality controls, and reporting standards can improve comparability across laboratories. Partnerships with hospitals, pathology services, regulators, and patient groups can clarify workflow requirements and evidence expectations. Organizations should also design interoperable data systems, monitor subgroup performance, protect genomic privacy, and establish transparent governance for algorithmic tools. Scalable sample logistics and training are especially important when extending testing beyond specialist centers.

Methodology: Evidence-Based Synthesis of Technology and Clinical Context

This executive summary uses a structured qualitative synthesis of the supplied market scope and established dimensions of ctDNA detection, including assay technologies, clinical applications, workflow requirements, regulation, infrastructure, and geographic implementation conditions. Interpretations should be anchored in peer-reviewed research, clinical-trial evidence, regulatory publications, laboratory standards, and health-system documentation. Findings are presented without market estimates, market shares, forecasts, or company-specific claims, and regional comparisons are framed around documented differences in capabilities, access, and policy context.

Conclusion: Clinical Value Depends on Evidence and Implementation Discipline

Cell-free tumor DNA detection is becoming an important component of precision oncology because it can provide repeatable molecular information without requiring repeated tissue acquisition. Its long-term role will depend less on technical sensitivity alone than on demonstrated patient benefit, reliable laboratory practice, appropriate interpretation, equitable access, and integration into clinical pathways. Industry leaders that combine rigorous evidence generation with transparent governance and practical implementation planning will be best positioned to translate ctDNA capabilities into dependable care.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Cell-free Tumor DNA Detection Market, by Products & Services
7.1. Introduction
7.2. Instruments
7.2.1. Automation Systems
7.2.2. Digital PCR Instruments
7.2.3. PCR Platforms
7.2.4. Sequencers
7.3. Reagents & Consumables
7.3.1. Assay Kits
7.3.2. Enzymes & Buffers
7.3.3. Extraction Kits
7.3.4. Library Preparation Kits
7.4. Services
7.4.1. Companion Diagnostic Development
7.4.2. Contract Research Services
7.4.3. Testing Services
7.5. Software & Bioinformatics
7.5.1. Cloud Platforms
7.5.2. Data Analysis Software
7.5.3. Interpretation & Reporting Tools
8. Cell-free Tumor DNA Detection Market, by Technology
8.1. Introduction
8.2. Next Generation Sequencing
8.2.1. Methylation Sequencing
8.2.2. Targeted Sequencing
8.2.3. Whole Exome Sequencing
8.2.4. Whole Genome Sequencing
8.3. Polymerase Chain Reaction
8.3.1. Digital PCR
8.3.2. qPCR
9. Cell-free Tumor DNA Detection Market, by Assay Format
9.1. Introduction
9.2. Methylation Panels
9.3. Single Gene Tests
9.4. Targeted Panels
9.5. Whole Exome
9.6. Whole Genome
10. Cell-free Tumor DNA Detection Market, by Biomarker Type
10.1. Introduction
10.2. Fragmentation Patterns
10.3. Gene Fusions
10.4. Methylation Markers
10.5. Somatic Mutations
11. Cell-free Tumor DNA Detection Market, by Cancer Type
11.1. Introduction
11.2. Breast Cancer
11.3. Colorectal Cancer
11.4. Hematological Cancers
11.5. Lung Cancer
11.6. Ovarian Cancer
11.7. Pancreatic Cancer
11.8. Prostate Cancer
12. Cell-free Tumor DNA Detection Market, by Sample Type
12.1. Introduction
12.2. Cerebrospinal Fluid
12.3. Plasma
12.4. Saliva
12.5. Serum
12.6. Urine
12.7. Whole Blood
13. Cell-free Tumor DNA Detection Market, by Application
13.1. Introduction
13.2. Companion Diagnostics
13.3. Early Detection & Screening
13.4. Minimal Residual Disease Monitoring
13.5. Prognosis & Recurrence Risk
13.6. Treatment Monitoring
14. Cell-free Tumor DNA Detection Market, by End User
14.1. Introduction
14.2. Contract Research Organizations
14.3. Diagnostic Laboratories
14.4. Hospitals & Clinics
14.5. Pharmaceutical & Biotechnology Companies
14.6. Research Institutes
15. Cell-free Tumor DNA Detection Market, by Region
15.1. Introduction
15.2. Asia-Pacific
15.3. North America
15.4. Latin America
15.5. Europe
15.6. Middle East
15.7. Africa
16. Cell-free Tumor DNA Detection Market, by Group
16.1. Introduction
16.2. ASEAN
16.3. GCC
16.4. European Union
16.5. BRICS
16.6. G7
16.7. NATO
17. Cell-free Tumor DNA Detection Market, by Country
17.1. Introduction
17.2. United States
17.3. Canada
17.4. Mexico
17.5. Brazil
17.6. United Kingdom
17.7. Germany
17.8. France
17.9. Russia
17.10. Italy
17.11. Spain
17.12. China
17.13. India
17.14. Japan
17.15. Australia
17.16. South Korea
18. Competitive Landscape
18.1. Market Share Analysis, 2025
18.2. Market Concentration Analysis, 2025
18.2.1. Concentration Ratio (CR)
18.2.2. Herfindahl Hirschman Index (HHI)
18.3. Recent Developments & Impact Analysis, 2025
18.4. Product Portfolio Analysis, 2025
18.5. Benchmarking Analysis, 2025
19. Company Profiles
19.1. Biocept, Inc.
19.2. Burning Rock Biotech Limited
19.3. C2i Genomics, Inc.
19.4. Exact Sciences Corporation
19.5. Exai Bio, Inc.
19.6. Fluxion Biosciences, Inc.
19.7. ForeSight Diagnostics, Inc.
19.8. Foundation Medicine, Inc.
19.9. Freenome Holdings, Inc.
19.10. GENECAST, Inc.
19.11. GRAIL, Inc.
19.12. Guardant Health, Inc.
19.13. Helio Health, Inc.
19.14. Inivata Limited
19.15. Laboratory Corporation of America Holdings
19.16. Natera, Inc.
19.17. Personalis, Inc.
19.18. Predicine, Inc.
19.19. Roche Sequencing Solutions, Inc.
19.20. Tempus AI, Inc.
20. Key Experts
LIST OF FIGURES
FIGURE 1. Global Cell-free Tumor DNA Detection Market, Years Considered for the Study
FIGURE 2. Global Cell-free Tumor DNA Detection Market, Research Design
FIGURE 3. Global Cell-free Tumor DNA Detection Market, Research Framework
FIGURE 4. Global Cell-free Tumor DNA Detection Market, Data Triangulation
FIGURE 5. Global Cell-free Tumor DNA Detection Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Cell-free Tumor DNA Detection Market Size, by Products & Services, 2025 vs 2032 (%)
FIGURE 7. Global Cell-free Tumor DNA Detection Market Size, by Products & Services, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Cell-free Tumor DNA Detection Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Cell-free Tumor DNA Detection Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Cell-free Tumor DNA Detection Market Size, by Assay Format, 2025 vs 2032 (%)
FIGURE 11. Global Cell-free Tumor DNA Detection Market Size, by Assay Format, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Cell-free Tumor DNA Detection Market Size, by Biomarker Type, 2025 vs 2032 (%)
FIGURE 13. Global Cell-free Tumor DNA Detection Market Size, by Biomarker Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Cell-free Tumor DNA Detection Market Size, by Cancer Type, 2025 vs 2032 (%)
FIGURE 15. Global Cell-free Tumor DNA Detection Market Size, by Cancer Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Cell-free Tumor DNA Detection Market Size, by Sample Type, 2025 vs 2032 (%)
FIGURE 17. Global Cell-free Tumor DNA Detection Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Cell-free Tumor DNA Detection Market Size, by Application, 2025 vs 2032 (%)
FIGURE 19. Global Cell-free Tumor DNA Detection Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Cell-free Tumor DNA Detection Market Size, by End User, 2025 vs 2032 (%)
FIGURE 21. Global Cell-free Tumor DNA Detection Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 22. Global Cell-free Tumor DNA Detection Market Size, by Region, 2025 vs 2032 (%)
FIGURE 23. Global Cell-free Tumor DNA Detection Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 24. Global Cell-free Tumor DNA Detection Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 25. Global Cell-free Tumor DNA Detection Market Size, by Country, 2025 vs 2032 (%)
FIGURE 26. Global Cell-free Tumor DNA Detection Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 27. Global Cell-free Tumor DNA Detection Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Cell-free Tumor DNA Detection Market Segmentation & Coverage
TABLE 2. Global Cell-free Tumor DNA Detection Market Size, 2017-2032 (USD Million)
TABLE 3. Global Cell-free Tumor DNA Detection Market Size, by Products & Services, 2017-2032 (USD Million)
TABLE 4. Global Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Automation Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Automation Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Automation Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Digital PCR Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Digital PCR Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Digital PCR Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global PCR Platforms Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global PCR Platforms Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global PCR Platforms Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Sequencers Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Sequencers Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Sequencers Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Reagents & Consumables Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Reagents & Consumables Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Reagents & Consumables Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Assay Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Assay Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Assay Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Enzymes & Buffers Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Enzymes & Buffers Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Enzymes & Buffers Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Extraction Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Extraction Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Extraction Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Library Preparation Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Library Preparation Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Library Preparation Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Companion Diagnostic Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Companion Diagnostic Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Companion Diagnostic Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Contract Research Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Contract Research Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Contract Research Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Testing Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Testing Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Testing Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Software & Bioinformatics Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Software & Bioinformatics Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Software & Bioinformatics Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Cloud Platforms Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Cloud Platforms Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Cloud Platforms Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Data Analysis Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Data Analysis Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Data Analysis Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Interpretation & Reporting Tools Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Interpretation & Reporting Tools Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Interpretation & Reporting Tools Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Cell-free Tumor DNA Detection Market Size, by Technology, 2017-2032 (USD Million)
TABLE 59. Global Next Generation Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Next Generation Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Next Generation Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Methylation Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Methylation Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Methylation Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Targeted Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Targeted Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Targeted Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Whole Exome Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Whole Exome Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Whole Exome Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Whole Genome Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Whole Genome Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Whole Genome Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Polymerase Chain Reaction Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Polymerase Chain Reaction Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Polymerase Chain Reaction Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Digital PCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Digital PCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Digital PCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global qPCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global qPCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global qPCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Cell-free Tumor DNA Detection Market Size, by Assay Format, 2017-2032 (USD Million)
TABLE 84. Global Methylation Panels Market Size, by Region, 2017-2032 (USD Million)
TABLE 85. Global Methylation Panels Market Size, by Group, 2017-2032 (USD Million)
TABLE 86. Global Methylation Panels Market Size, by Country, 2017-2032 (USD Million)
TABLE 87. Global Single Gene Tests Market Size, by Region, 2017-2032 (USD Million)
TABLE 88. Global Single Gene Tests Market Size, by Group, 2017-2032 (USD Million)
TABLE 89. Global Single Gene Tests Market Size, by Country, 2017-2032 (USD Million)
TABLE 90. Global Targeted Panels Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Global Targeted Panels Market Size, by Group, 2017-2032 (USD Million)
TABLE 92. Global Targeted Panels Market Size, by Country, 2017-2032 (USD Million)
TABLE 93. Global Whole Exome Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Global Whole Exome Market Size, by Group, 2017-2032 (USD Million)
TABLE 95. Global Whole Exome Market Size, by Country, 2017-2032 (USD Million)
TABLE 96. Global Whole Genome Market Size, by Region, 2017-2032 (USD Million)
TABLE 97. Global Whole Genome Market Size, by Group, 2017-2032 (USD Million)
TABLE 98. Global Whole Genome Market Size, by Country, 2017-2032 (USD Million)
TABLE 99. Global Cell-free Tumor DNA Detection Market Size, by Biomarker Type, 2017-2032 (USD Million)
TABLE 100. Global Fragmentation Patterns Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Fragmentation Patterns Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Fragmentation Patterns Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Gene Fusions Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Gene Fusions Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Gene Fusions Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global Methylation Markers Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global Methylation Markers Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global Methylation Markers Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global Somatic Mutations Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global Somatic Mutations Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global Somatic Mutations Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global Cell-free Tumor DNA Detection Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 113. Global Breast Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Global Breast Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. Global Breast Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 116. Global Colorectal Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Global Colorectal Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. Global Colorectal Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 119. Global Hematological Cancers Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Global Hematological Cancers Market Size, by Group, 2017-2032 (USD Million)
TABLE 121. Global Hematological Cancers Market Size, by Country, 2017-2032 (USD Million)
TABLE 122. Global Lung Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Global Lung Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 124. Global Lung Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 125. Global Ovarian Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 126. Global Ovarian Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. Global Ovarian Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 128. Global Pancreatic Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 129. Global Pancreatic Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 130. Global Pancreatic Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 131. Global Prostate Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 132. Global Prostate Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 133. Global Prostate Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 134. Global Cell-free Tumor DNA Detection Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 135. Global Cerebrospinal Fluid Market Size, by Region, 2017-2032 (USD Million)
TABLE 136. Global Cerebrospinal Fluid Market Size, by Group, 2017-2032 (USD Million)
TABLE 137. Global Cerebrospinal Fluid Market Size, by Country, 2017-2032 (USD Million)
TABLE 138. Global Plasma Market Size, by Region, 2017-2032 (USD Million)
TABLE 139. Global Plasma Market Size, by Group, 2017-2032 (USD Million)
TABLE 140. Global Plasma Market Size, by Country, 2017-2032 (USD Million)
TABLE 141. Global Saliva Market Size, by Region, 2017-2032 (USD Million)
TABLE 142. Global Saliva Market Size, by Group, 2017-2032 (USD Million)
TABLE 143. Global Saliva Market Size, by Country, 2017-2032 (USD Million)
TABLE 144. Global Serum Market Size, by Region, 2017-2032 (USD Million)
TABLE 145. Global Serum Market Size, by Group, 2017-2032 (USD Million)
TABLE 146. Global Serum Market Size, by Country, 2017-2032 (USD Million)
TABLE 147. Global Urine Market Size, by Region, 2017-2032 (USD Million)
TABLE 148. Global Urine Market Size, by Group, 2017-2032 (USD Million)
TABLE 149. Global Urine Market Size, by Country, 2017-2032 (USD Million)
TABLE 150. Global Whole Blood Market Size, by Region, 2017-2032 (USD Million)
TABLE 151. Global Whole Blood Market Size, by Group, 2017-2032 (USD Million)
TABLE 152. Global Whole Blood Market Size, by Country, 2017-2032 (USD Million)
TABLE 153. Global Cell-free Tumor DNA Detection Market Size, by Application, 2017-2032 (USD Million)
TABLE 154. Global Companion Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 155. Global Companion Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 156. Global Companion Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 157. Global Early Detection & Screening Market Size, by Region, 2017-2032 (USD Million)
TABLE 158. Global Early Detection & Screening Market Size, by Group, 2017-2032 (USD Million)
TABLE 159. Global Early Detection & Screening Market Size, by Country, 2017-2032 (USD Million)
TABLE 160. Global Minimal Residual Disease Monitoring Market Size, by Region, 2017-2032 (USD Million)
TABLE 161. Global Minimal Residual Disease Monitoring Market Size, by Group, 2017-2032 (USD Million)
TABLE 162. Global Minimal Residual Disease Monitoring Market Size, by Country, 2017-2032 (USD Million)
TABLE 163. Global Prognosis & Recurrence Risk Market Size, by Region, 2017-2032 (USD Million)
TABLE 164. Global Prognosis & Recurrence Risk Market Size, by Group, 2017-2032 (USD Million)
TABLE 165. Global Prognosis & Recurrence Risk Market Size, by Country, 2017-2032 (USD Million)
TABLE 166. Global Treatment Monitoring Market Size, by Region, 2017-2032 (USD Million)
TABLE 167. Global Treatment Monitoring Market Size, by Group, 2017-2032 (USD Million)
TABLE 168. Global Treatment Monitoring Market Size, by Country, 2017-2032 (USD Million)
TABLE 169. Global Cell-free Tumor DNA Detection Market Size, by End User, 2017-2032 (USD Million)
TABLE 170. Global Contract Research Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 171. Global Contract Research Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 172. Global Contract Research Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 173. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 174. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 175. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 176. Global Hospitals & Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 177. Global Hospitals & Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 178. Global Hospitals & Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 179. Global Pharmaceutical & Biotechnology Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 180. Global Pharmaceutical & Biotechnology Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 181. Global Pharmaceutical & Biotechnology Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 182. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 183. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 184. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 185. Global Cell-free Tumor DNA Detection Market Size, by Region, 2017-2032 (USD Million)
TABLE 186. Asia-Pacific Cell-free Tumor DNA Detection Market Size, by Region, 2017-2032 (USD Million)
TABLE 187. Asia-Pacific Cell-free Tumor DNA Detection Market Size, by Products & Services, 2017-2032 (USD Million)
TABLE 188. Asia-Pacific Cell-free Tumor DNA Detection Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 189. Asia-Pacific Cell-free Tumor DNA Detection Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 190. Asia-Pacific Cell-free Tumor DNA Detection Market Size, by Services, 2017-2032 (USD Million)
TABLE 191. Asia-Pacific Cell-free Tumor DNA Detection Market Size, by Software & Bioinformatics, 2017-2032 (USD Million)
TABLE 192. Asia-Pacific Cell-free Tumor DNA Detection Market Size, by Technology, 2017-2032 (USD Million)
TABLE 193. Asia-Pacific Cell-free Tumor DNA Detection Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 194. Asia-Pacific Cell-free Tumor DNA Detection Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 195. Asia-Pacific Cell-free Tumor DNA Detection Market Size, by Assay Format, 2017-2032 (USD Million)
TABLE 196. Asia-Pacific Cell-free Tumor DNA Detection Market Size, by Biomarker Type, 2017-2032 (USD Million)
TABLE 197. Asia-Pacific Cell-free Tumor DNA Detection Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 198. Asia-Pacific Cell-free Tumor DNA Detection Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 199. Asia-Pacific Cell-free Tumor DNA Detection Market Size, by Application, 2017-2032 (USD Million)
TABLE 200. Asia-Pacific Cell-free Tumor DNA Detection Market Size, by End User, 2017-2032 (USD Million)
TABLE 201. North America Cell-free Tumor DNA Detection Market Size, by Region, 2017-2032 (USD Million)
TABLE 202. North America Cell-free Tumor DNA Detection Market Size, by Products & Services, 2017-2032 (USD Million)
TABLE 203. North America Cell-free Tumor DNA Detection Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 204. North America Cell-free Tumor DNA Detection Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 205. North America Cell-free Tumor DNA Detection Market Size, by Services, 2017-2032 (USD Million)
TABLE 206. North America Cell-free Tumor DNA Detection Market Size, by Software & Bioinformatics, 2017-2032 (USD Million)
TABLE 207. North America Cell-free Tumor DNA Detection Market Size, by Technology, 2017-2032 (USD Million)
TABLE 208. North America Cell-free Tumor DNA Detection Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 209. North America Cell-free Tumor DNA Detection Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 210. North America Cell-free Tumor DNA Detection Market Size, by Assay Format, 2017-2032 (USD Million)
TABLE 211. North America Cell-free Tumor DNA Detection Market Size, by Biomarker Type, 2017-2032 (USD Million)
TABLE 212. North America Cell-free Tumor DNA Detection Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 213. North America Cell-free Tumor DNA Detection Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 214. North America Cell-free Tumor DNA Detection Market Size, by Application, 2017-2032 (USD Million)
TABLE 215. North America Cell-free Tumor DNA Detection Market Size, by End User, 2017-2032 (USD Million)
TABLE 216. Latin America Cell-free Tumor DNA Detection Market Size, by Region, 2017-2032 (USD Million)
TABLE 217. Latin America Cell-free Tumor DNA Detection Market Size, by Products & Services, 2017-2032 (USD Million)
TABLE 218. Latin America Cell-free Tumor DNA Detection Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 219. Latin America Cell-free Tumor DNA Detection Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 220. Latin America Cell-free Tumor DNA Detection Market Size, by Services, 2017-2032 (USD Million)
TABLE 221. Latin America Cell-free Tumor DNA Detection Market Size, by Software & Bioinformatics, 2017-2032 (USD Million)
TABLE 222. Latin America Cell-free Tumor DNA Detection Market Size, by Technology, 2017-2032 (USD Million)
TABLE 223. Latin America Cell-free Tumor DNA Detection Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 224. Latin America Cell-free Tumor DNA Detection Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 225. Latin America Cell-free Tumor DNA Detection Market Size, by Assay Format, 2017-2032 (USD Million)
TABLE 226. Latin America Cell-free Tumor DNA Detection Market Size, by Biomarker Type, 2017-2032 (USD Million)
TABLE 227. Latin America Cell-free Tumor DNA Detection Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 228. Latin America Cell-free Tumor DNA Detection Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 229. Latin America Cell-free Tumor DNA Detection Market Size, by Application, 2017-2032 (USD Million)
TABLE 230. Latin America Cell-free Tumor DNA Detection Market Size, by End User, 2017-2032 (USD Million)
TABLE 231. Europe Cell-free Tumor DNA Detection Market Size, by Region, 2017-2032 (USD Million)
TABLE 232. Europe Cell-free Tumor DNA Detection Market Size, by Products & Services, 2017-2032 (USD Million)
TABLE 233. Europe Cell-free Tumor DNA Detection Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 234. Europe Cell-free Tumor DNA Detection Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 235. Europe Cell-free Tumor DNA Detection Market Size, by Services, 2017-2032 (USD Million)
TABLE 236. Europe Cell-free Tumor DNA Detection Market Size, by Software & Bioinformatics, 2017-2032 (USD Million)
TABLE 237. Europe Cell-free Tumor DNA Detection Market Size, by Technology, 2017-2032 (USD Million)
TABLE 238. Europe Cell-free Tumor DNA Detection Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 239. Europe Cell-free Tumor DNA Detection Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 240. Europe Cell-free Tumor DNA Detection Market Size, by Assay Format, 2017-2032 (USD Million)
TABLE 241. Europe Cell-free Tumor DNA Detection Market Size, by Biomarker Type, 2017-2032 (USD Million)
TABLE 242. Europe Cell-free Tumor DNA Detection Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 243. Europe Cell-free Tumor DNA Detection Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 244. Europe Cell-free Tumor DNA Detection Market Size, by Application, 2017-2032 (USD Million)
TABLE 245. Europe Cell-free Tumor DNA Detection Market Size, by End User, 2017-2032 (USD Million)
TABLE 246. Middle East Cell-free Tumor DNA Detection Market Size, by Region, 2017-2032 (USD Million)
TABLE 247. Middle East Cell-free Tumor DNA Detection Market Size, by Products & Services, 2017-2032 (USD Million)
TABLE 248. Middle East Cell-free Tumor DNA Detection Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 249. Middle East Cell-free Tumor DNA Detection Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 250. Middle East Cell-free Tumor DNA Detection Market Size, by Services, 2017-2032 (USD Million)
TABLE 251. Middle East Cell-free Tumor DNA Detection Market Size, by Software & Bioinformatics, 2017-2032 (USD Million)
TABLE 252. Middle East Cell-free Tumor DNA Detection Market Size, by Technology, 2017-2032 (USD Million)
TABLE 253. Middle East Cell-free Tumor DNA Detection Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 254. Middle East Cell-free Tumor DNA Detection Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 255. Middle East Cell-free Tumor DNA Detection Market Size, by Assay Format, 2017-2032 (USD Million)
TABLE 256. Middle East Cell-free Tumor DNA Detection Market Size, by Biomarker Type, 2017-2032 (USD Million)
TABLE 257. Middle East Cell-free Tumor DNA Detection Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 258. Middle East Cell-free Tumor DNA Detection Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 259. Middle East Cell-free Tumor DNA Detection Market Size, by Application, 2017-2032 (USD Million)
TABLE 260. Middle East Cell-free Tumor DNA Detection Market Size, by End User, 2017-2032 (USD Million)
TABLE 261. Africa Cell-free Tumor DNA Detection Market Size, by Region, 2017-2032 (USD Million)
TABLE 262. Africa Cell-free Tumor DNA Detection Market Size, by Products & Services, 2017-2032 (USD Million)
TABLE 263. Africa Cell-free Tumor DNA Detection Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 264. Africa Cell-free Tumor DNA Detection Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 265. Africa Cell-free Tumor DNA Detection Market Size, by Services, 2017-2032 (USD Million)
TABLE 266. Africa Cell-free Tumor DNA Detection Market Size, by Software & Bioinformatics, 2017-2032 (USD Million)
TABLE 267. Africa Cell-free Tumor DNA Detection Market Size, by Technology, 2017-2032 (USD Million)
TABLE 268. Africa Cell-free Tumor DNA Detection Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 269. Africa Cell-free Tumor DNA Detection Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 270. Africa Cell-free Tumor DNA Detection Market Size, by Assay Format, 2017-2032 (USD Million)
TABLE 271. Africa Cell-free Tumor DNA Detection Market Size, by Biomarker Type, 2017-2032 (USD Million)
TABLE 272. Africa Cell-free Tumor DNA Detection Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 273. Africa Cell-free Tumor DNA Detection Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 274. Africa Cell-free Tumor DNA Detection Market Size, by Application, 2017-2032 (USD Million)
TABLE 275. Africa Cell-free Tumor DNA Detection Market Size, by End User, 2017-2032 (USD Million)
TABLE 276. Global Cell-free Tumor DNA Detection Market Size, by Group, 2017-2032 (USD Million)
TABLE 277. ASEAN Cell-free Tumor DNA Detection Market Size, by Group, 2017-2032 (USD Million)
TABLE 278. ASEAN Cell-free Tumor DNA Detection Market Size, by Products & Services, 2017-2032 (USD Million)
TABLE 279. ASEAN Cell-free Tumor DNA Detection Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 280. ASEAN Cell-free Tumor DNA Detection Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 281. ASEAN Cell-free Tumor DNA Detection Market Size, by Services, 2017-2032 (USD Million)
TABLE 282. ASEAN Cell-free Tumor DNA Detection Market Size, by Software & Bioinformatics, 2017-2032 (USD Million)
TABLE 283. ASEAN Cell-free Tumor DNA Detection Market Size, by Technology, 2017-2032 (USD Million)
TABLE 284. ASEAN Cell-free Tumor DNA Detection Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 285. ASEAN Cell-free Tumor DNA Detection Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 286. ASEAN Cell-free Tumor DNA Detection Market Size, by Assay Format, 2017-2032 (USD Million)
TABLE 287. ASEAN Cell-free Tumor DNA Detection Market Size, by Biomarker Type, 2017-2032 (USD Million)
TABLE 288. ASEAN Cell-free Tumor DNA Detection Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 289. ASEAN Cell-free Tumor DNA Detection Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 290. ASEAN Cell-free Tumor DNA Detection Market Size, by Application, 2017-2032 (USD Million)
TABLE 291. ASEAN Cell-free Tumor DNA Detection Market Size, by End User, 2017-2032 (USD Million)
TABLE 292. GCC Cell-free Tumor DNA Detection Market Size, by Group, 2017-2032 (USD Million)
TABLE 293. GCC Cell-free Tumor DNA Detection Market Size, by Products & Services, 2017-2032 (USD Million)
TABLE 294. GCC Cell-free Tumor DNA Detection Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 295. GCC Cell-free Tumor DNA Detection Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 296. GCC Cell-free Tumor DNA Detection Market Size, by Services, 2017-2032 (USD Million)
TABLE 297. GCC Cell-free Tumor DNA Detection Market Size, by Software & Bioinformatics, 2017-2032 (USD Million)
TABLE 298. GCC Cell-free Tumor DNA Detection Market Size, by Technology, 2017-2032 (USD Million)
TABLE 299. GCC Cell-free Tumor DNA Detection Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 300. GCC Cell-free Tumor DNA Detection Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 301. GCC Cell-free Tumor DNA Detection Market Size, by Assay Format, 2017-2032 (USD Million)
TABLE 302. GCC Cell-free Tumor DNA Detection Market Size, by Biomarker Type, 2017-2032 (USD Million)
TABLE 303. GCC Cell-free Tumor DNA Detection Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 304. GCC Cell-free Tumor DNA Detection Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 305. GCC Cell-free Tumor DNA Detection Market Size, by Application, 2017-2032 (USD Million)
TABLE 306. GCC Cell-free Tumor DNA Detection Market Size, by End User, 2017-2032 (USD Million)
TABLE 307. European Union Cell-free Tumor DNA Detection Market Size, by Group, 2017-2032 (USD Million)
TABLE 308. European Union Cell-free Tumor DNA Detection Market Size, by Products & Services, 2017-2032 (USD Million)
TABLE 309. European Union Cell-free Tumor DNA Detection Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 310. European Union Cell-free Tumor DNA Detection Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 311. European Union Cell-free Tumor DNA Detection Market Size, by Services, 2017-2032 (USD Million)
TABLE 312. European Union Cell-free Tumor DNA Detection Market Size, by Software & Bioinformatics, 2017-2032 (USD Million)
TABLE 313. European Union Cell-free Tumor DNA Detection Market Size, by Technology, 2017-2032 (USD Million)
TABLE 314. European Union Cell-free Tumor DNA Detection Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 315. European Union Cell-free Tumor DNA Detection Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 316. European Union Cell-free Tumor DNA Detection Market Size, by Assay Format, 2017-2032 (USD Million)
TABLE 317. European Union Cell-free Tumor DNA Detection Market Size, by Biomarker Type, 2017-2032 (USD Million)
TABLE 318. European Union Cell-free Tumor DNA Detection Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 319. European Union Cell-free Tumor DNA Detection Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 320. European Union Cell-free Tumor DNA Detection Market Size, by Application, 2017-2032 (USD Million)
TABLE 321. European Union Cell-free Tumor DNA Detection Market Size, by End User, 2017-2032 (USD Million)
TABLE 322. BRICS Cell-free Tumor DNA Detection Market Size, by Group, 2017-2032 (USD Million)
TABLE 323. BRICS Cell-free Tumor DNA Detection Market Size, by Products & Services, 2017-2032 (USD Million)
TABLE 324. BRICS Cell-free Tumor DNA Detection Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 325. BRICS Cell-free Tumor DNA Detection Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 326. BRICS Cell-free Tumor DNA Detection Market Size, by Services, 2017-2032 (USD Million)
TABLE 327. BRICS Cell-free Tumor DNA Detection Market Size, by Software & Bioinformatics, 2017-2032 (USD Million)
TABLE 328. BRICS Cell-free Tumor DNA Detection Market Size, by Technology, 2017-2032 (USD Million)
TABLE 329. BRICS Cell-free Tumor DNA Detection Market Size, by Next Generation Sequencing, 2017-2032 (USD Million)
TABLE 330. BRICS Cell-free Tumor DNA Detection Market Size, by Polymerase Chain Reaction, 2017-2032 (USD Million)
TABLE 331. BRICS Cell-free Tumor DNA Detection Market Size, by Assay Format, 2017-2032 (USD Million)
TABLE 332. BRICS Cell-free Tumor DNA Detection Market Size, by Biomarker Type, 2017-2032 (USD Million)
TABLE 333. BRICS Cell-free Tumor DNA Detection Market Size, by Cancer Type, 2017-2032 (USD Million)
TABLE 334. BRICS Cell-free Tumor DNA Detection Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 335. BRICS Cell-free Tumor DNA Detection Market Size, by Application, 2017-2032 (USD Million)
TABLE 336. BRICS Cell-free Tumor DNA Detection Market Size, by End User, 2017-2032 (USD Million)
TABLE 337. G7 Cell-free Tumor DNA Detection Market Size, by Group, 2017-2032 (USD Million)
TABLE 338. G7 Cell-free Tumor DNA Detection Market Size, by Products & Services, 2017-2032 (USD Million)
TABLE 339. G7 Cell-free Tumor DNA Detection Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 340. G7 Cell-free Tumor DNA Detection Market Size, by Reagents & Consumables, 2017-2032 (USD Million)
TABLE 341. G7 Cell-free Tumor DNA Detection Market Size, by Services, 2017-2032 (USD Million)
TABLE 342. G7 Cell-free Tumor DNA Detection Market Size, by Software & Bioinformatics, 2017-2032 (USD Million)
TABLE 343. G7 Cell-free Tumor DNA Detection Market Size, by Technology, 2017-2032 (USD Million)
TABLE 344. G7 Cell-free Tumor DNA Detection Market Size, by Next Gen

Companies Mentioned

  • Biocept, Inc.
  • Burning Rock Biotech Limited
  • C2i Genomics, Inc.
  • Exact Sciences Corporation
  • Exai Bio, Inc.
  • Fluxion Biosciences, Inc.
  • ForeSight Diagnostics, Inc.
  • Foundation Medicine, Inc.
  • Freenome Holdings, Inc.
  • GENECAST, Inc.
  • GRAIL, Inc.
  • Guardant Health, Inc.
  • Helio Health, Inc.
  • Inivata Limited
  • Laboratory Corporation of America Holdings
  • Natera, Inc.
  • Personalis, Inc.
  • Predicine, Inc.
  • Roche Sequencing Solutions, Inc.
  • Tempus AI, Inc.

Related Reports

Liquid Biopsy Market - Global Forecast 2026-2032 - Product Image

Liquid Biopsy Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Cell-free DNA Mutation Diagnostics Market - Global Forecast 2026-2032 - Product Image

Cell-free DNA Mutation Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 194 Pages
  • Global
From
Breast Cancer Liquid Biopsy Market - Global Forecast 2026-2032 - Product Image

Breast Cancer Liquid Biopsy Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Circulating Tumor DNA Diagnostics Market - Global Forecast 2026-2032 - Product Image

Circulating Tumor DNA Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 190 Pages
  • Global
From
Breast Cancer Liquid Biopsy Testing Devices Market - Global Forecast 2026-2032 - Product Image

Breast Cancer Liquid Biopsy Testing Devices Market - Global Forecast 2026-2032

  • Report
  • 183 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.